This analysis examines the historical and forecast performance for AstraZeneca in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, wit...
|
$ 5700
|
|
|
The difficulties with using the standard therapy, warfarin, in this indication have led to the development of the novel oral anticoagulants. Uptake of the two marketed novel therapies, Pradaxa and Xarelto, has been slower than expected. However, t...
|
$ 11400
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets around the world. The analyses provide essential market information for decision-makers including: Argent...
|
$ 24584
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in Europe. The analyses provide essential market information for decision-makers including: Armenia, Aust...
|
$ 13024
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in Asia. The analyses provide essential market information for decision-makers including: Bangladesh, Chi...
|
$ 10564
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in Americas. The analyses provide essential market information for decision-makers including: Argentina, ...
|
$ 5276
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp in Africa. The analyses provide essential market information for decision-makers including: Egypt, Eritrea, Ethio...
|
$ 3308
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp in Eastern Europe. The analyses provide essential market information for decision-makers including: Armenia, Azer...
|
$ 8105
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp in Western Europe. The analyses provide essential market information for decision-makers including: Austria, Belg...
|
$ 6629
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in top 10 countries around the world. The analyses provide essential market information for decision-make...
|
$ 4784
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in top 5 countries in Europe. The analyses provide essential market information for decision-makers inclu...
|
$ 2324
|
|
|
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for pulp markets in top 5 countries in Asia. The analyses provide essential market information for decision-makers includi...
|
$ 2324
|
|
|
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers...
|
$ 3800
|
|
|
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers...
|
$ 3800
|
|
|
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers...
|
$ 3800
|
|
|
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers...
|
$ 3800
|
|
|
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers...
|
$ 3800
|
|
|
China's demand for industrial lubricants has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, indust...
|
$ 4000
|
|
|
Biomet is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a number of emerging markets. Throughout its history, the company has also expanded into areas such as sports medicine...
|
$ 1995
|
|
|
Zimmer is a strong player in the large joint replacement market. Zimmer’s reconstructive unit accounted for over 75% of its global revenue, and the company saw strong growth in the hip and extremity segments of its reconstructive sectors. Zi...
|
$ 1995
|
|
|
The vast majority of Smith & Nephew’ revenue was earned from the company’s orthopedics business unit. Smith & Nephew posted strong revenue growth over the first three quarters of 2010. The company’s Orthopedics, Endoscopy...
|
$ 1995
|
|
|